Waiting for a pacemaker: Is it dangerous?

Europace

Volumn 14, Issue 7, 2012, Pages 975-980

  Risgaard, Bjarke ^a   Elming, Hanne ^a   Jensen, Gunnar V ^a   Johansen, Jens B ^b   Toft, Jens Christian ^c  

^a ROSKILDE HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c SLAGELSE HOSPITAL   (Denmark)

Author keywords

Acute; Complications; Implantation; Pacemaker; Waiting period

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ISOPRENALINE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTIFICIAL HEART PACEMAKER; DENMARK; FEMALE; HEART ARREST; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RESUSCITATION; RETROSPECTIVE STUDY; REVIEW; URINARY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; DENMARK; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; SURVIVAL ANALYSIS; SURVIVAL RATE; WAITING LISTS;

EID: 84862997368     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus016     Document Type: Review

References (14)

1. Lau CP, Siu CW. Pacing technology: advances in pacing threshold management. J Zhejiang Univ Sci B 2010;11:634-8.
2. Sodeck GH, Domanovits H, Meron G, Rauscha F, Losert H, Thalmann M et al. Compromising bradycardia: management in the emergency department. Resuscitation 2007;73:96-102.
3. Cohen SI, Smith LK, Aoresty JM, Voukydis P, Morkin E. Atrioventricular conduction in patients with clinical indications for transvenous cardiac pacing. Br Heart J 1975;37:583-92.
4. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002;106:2145-61.
5. Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Europace 2007;9:959-98.
6. Brembilla-Perrot B, Muhanna I, Nippert M, Popovic B, Beurrier D, Houriez P et al. Paradoxical effect of isoprenaline infusion. Europace 2005;7:621-7.
7. Harrigan RA, Chan TC, Moonblatt S, Vilke GM, Ufberg JW. Temporary transvenous pacemaker placement in the emergency department. J Emerg Med 2007;32: 105-11.
8. Vukov LF, Johnson DQ. External transcutaneous pacemakers in interhospital transport of cardiac patients. Ann Emerg Med 1989;18:738-40.
9. Cunnington MS, Plummer CJ, Mccomb JM. Delays and adverse clinical outcomes associated with unrecognized pacing indications. QJM 2009;102:485-90.
10. Simpson CS, Fisher MA, Curtis MJ, Krahn AD, Abdollah H, Raj SR et al. Correlation of waiting time with adverse events in patients admitted for nonelective permanent pacemaker implantation. Can J Cardiol 1998;14:817-21.
11. Johansen JB, Jorgensen OD, Moller M, Arnsbo P, Mortensen PT, Nielsen JC. Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J 2011;32:991-8.
12. Bloom H, Heeke B, Leon A, Mera F, Delurgio D, Beshai J et al. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol 2006;29:142-5.
13. Cunnington MS, Plummer CJ, McDiarmid AK, Mccomb JM. The patient journey from symptom onset to pacemaker implantation. QJM 2008;101:955-60.
14. Laczika K, Thalhammer F, Locker G, Apsner R, Losert H, Kofler J et al. Safe and efficient emergency transvenous ventricular pacing via the right supraclavicular route. Anesth Analg 2000;90:784-9.